AbolerIS Pharma
Latest round
- Seed
Last raised
- Mar 2021
Total raised
- $1.9M
Investors
- 3
About AbolerIS Pharma
Founded in 2019 in Nantes, France, AbolerIS Pharma focuses on advanced biopharmaceuticals for autoimmune conditions.25 million.Aboleris Pharma specializes in novel therapeutics aimed at regulating the immune system. Their core product offerings focus on advanced biopharmaceuticals that target autoimmune disorders and enhance immune response. These therapeutics address significant unmet medical needs in conditions like rheumatoid arthritis, lupus, and multiple sclerosis, among others. Aboleris Pharma's products are engineered using proprietary technology that modulates immune pathways to achieve targeted therapeutic effects.Aboleris Pharma generates revenue through a combination of direct sales and strategic partnerships with healthcare providers and research institutions. Transactions typically occur through a business-to-business model, where products are sold to hospitals, clinics, and specialty pharmacies. The company's flagship products are integrated into treatment protocols for various autoimmune conditions, and pricing is structured to reflect the value provided to healthcare providers and patients alike. The company is focused on launching new products designed to enhance immune regulation, although specific release dates have not been disclosed. Additionally, AbolerIS Pharma plans to expand into new markets in Europe and North America by 2023, aiming to increase its footprint in these regions.
Who invested in AbolerIS Pharma
3 investors across 1 round
See all investors in AbolerIS Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 17, 2021
Amount
$1.9M
Investors
Questions about AbolerIS Pharma
Who invested in AbolerIS Pharma?
AbolerIS Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AbolerIS Pharma raised?
AbolerIS Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AbolerIS Pharma last raise money?
AbolerIS Pharma's most recent round on record is a Seed, in Mar 2021.
What does AbolerIS Pharma do?
Founded in 2019 in Nantes, France, AbolerIS Pharma focuses on advanced biopharmaceuticals for autoimmune conditions.
Where is AbolerIS Pharma headquartered?
AbolerIS Pharma is headquartered in Nantes, France.
Which VCs invest in companies like AbolerIS Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at AbolerIS Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like AbolerIS Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.